| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,914 | 54,459 | 60,468 | 65,379 | | Cost of Revenue | 38,509 | 42,097 | 46,781 | 48,881 | | | Gross Profit | 11,405 | 12,362 | 13,687 | 16,498 | | | Operating Expenses | | Research Development | 3,770 | 3,048 | 3,309 | 3,724 | | Selling General and Administrative | 8,579 | 8,647 | 9,595 | 9,866 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 371 | 368 | 365 | 368 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,315) | 299 | 418 | 2,540 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 156 | 107 | 162 | | Earnings Before Interest And Taxes | (1,304) | 455 | 525 | 2,702 | | Interest Expense | 106 | 83 | 139 | 431 | | Income Before Tax | (1,410) | 372 | 386 | 2,271 | | Income Tax Expense | (632) | 134 | 139 | 811 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (778) | 238 | 247 | 1,460 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (778) | 238 | 247 | 1,460 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($778) | $238 | $247 | $1,460 |
|
0.31% Nasdaq 0.00%
Income Statement
